iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments
Neil Gallagher M.D., Ph.D., former AbbVie Chief Medical Officer and President of R&D at Syndax, brings considerable experience in oncology drug development Anthony Mancini, currently Global Chief Commercial Officer at Revolution Medicines, led several successful oncology product launches at Genmab and BMS GENEVA, AMSTERDAM, and CAMBRIDGE, Mass., July 24, 2025 /PRNewswire/ — iOnctura, a clinical-stage […]







